Attached files

file filename
EX-32.2 - EX-32.2 - Orchard Therapeutics plcortx-ex322_8.htm
EX-32.1 - EX-32.1 - Orchard Therapeutics plcortx-ex321_10.htm
EX-31.2 - EX-31.2 - Orchard Therapeutics plcortx-ex312_14.htm
EX-31.1 - EX-31.1 - Orchard Therapeutics plcortx-ex311_16.htm
EX-21.1 - EX-21.1 - Orchard Therapeutics plcortx-ex211_6.htm
10-K - 10-K - Orchard Therapeutics plcortx-10k_20201231.htm

 

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-230432, 333-228067 and 333-241646) and Form S-3 (No. 333-234439) of Orchard Therapeutics plc of our report dated March 2, 2021 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

March 2, 2021

1